SLC2A1 and colorectal carcinoma: For example, Chen et al. showed that METTL3 contributed to CRC cell nutrition (GLUT1 Canal) and mTORC1 signal activation, making METTL3 a potential prognosis marker of CRC patients [27,28,29].